Preparing for Lab Inspections

📋 Essential QMS Documents & Their Regulatory References in Pharmaceutical Manufacturing A strong Pharmaceutical Quality System (PQS) is the backbone of GMP compliance. Below are some of the key Quality Management System (QMS) documents and the major regulatory expectations behind them: ✅ Quality Manual – ICH Q10 (Section 2), EU GMP Chapter 1 ✅ Document Control SOP – FDA 21 CFR 211.180, EU GMP Chapter 4 ✅ Change Control – ICH Q10 (Section 3.2.3), EU GMP Chapter 1 ✅ Deviation Management – FDA 21 CFR 211.100 & 211.192, EU GMP Chapter 1 ✅ CAPA (Corrective & Preventive Action) – ICH Q10 (Section 3.2.2), FDA 21 CFR 211.192 ✅ Risk Management – ICH Q9(R1), ICH Q10 ✅ Complaint Handling – FDA 21 CFR 211.198, EU GMP Chapter 8 ✅ Product Recall Procedure – FDA 21 CFR 211.150, EU GMP Chapter 8 ✅ Internal Audit (Self-Inspection) – EU GMP Chapter 9 ✅ Training Records – FDA 21 CFR 211.25, EU GMP Chapter 2 ✅ Supplier Qualification – EU GMP Chapter 5 & Chapter 7 ✅ Validation Master Plan (VMP) – EU GMP Annex 15 ✅ Equipment Qualification (DQ/IQ/OQ/PQ) – EU GMP Annex 15 ✅ Cleaning Validation – EU GMP Annex 15 ✅ Process Validation – FDA 21 CFR 211.100, EU GMP Annex 15 ✅ Annual Product Quality Review (APQR/PQR) – FDA 21 CFR 211.180(e), EU GMP Chapter 1 ✅ Data Integrity & Electronic Records – FDA 21 CFR Part 11, EU GMP Annex 11 💡 A well-designed QMS is not just about regulatory compliance—it drives product quality, patient safety, operational excellence, and continuous improvement throughout the product lifecycle. #Pharmaceuticals #QualityManagement #QMS #PQS #GMP #USFDA #MHRA #EU_GMP #ICHQ10 #ICHQ9 #CAPA #Validation #DataIntegrity #RegulatoryAffairs #QualityAssurance

🧾 𝗠𝗮𝘀𝘁𝗲𝗿 𝗖𝗼𝗻𝘀𝗼𝗹𝗶𝗱𝗮𝘁𝗲𝗱 𝗤𝗔/𝗤𝗖 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗟𝗶𝘀𝘁 – 𝗙𝗮𝗯𝗿𝗶𝗰𝗮𝘁𝗶𝗼𝗻 & 𝗖𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗷𝗲𝗰𝘁𝘀 In engineering projects, documentation is the DNA of quality. It’s not just paperwork — it’s the technical history of how a structure or system was built, inspected, and approved. I’ve compiled a complete consolidated QA/QC document list covering every stage from: Project Initiation → Material → Welding → NDT → Painting → Testing → Handover. It includes more than 50 essential QA/QC records, all in one place. Perfect for QA/QC Engineers, Inspectors, and Project Managers who live by: 🗒️ “If it’s not documented — it’s not done.” ✅ ────────────────────────────── 🔹 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁 𝗖𝗮𝘁𝗲𝗴𝗼𝗿𝗶𝗲𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 ────────────────────────────── 1️⃣ 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗜𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝗼𝗻 & 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗣𝗹𝗮𝗻𝗻𝗶𝗻𝗴 2️⃣ 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗼𝗹 & 𝗧𝗿𝗮𝗰𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆 3️⃣ 𝗪𝗲𝗹𝗱𝗶𝗻𝗴 & 𝗙𝗮𝗯𝗿𝗶𝗰𝗮𝘁𝗶𝗼𝗻 4️⃣ 𝗡𝗗𝗧 & 𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝗰𝗮𝗹 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 5️⃣ 𝗣𝗮𝗶𝗻𝘁𝗶𝗻𝗴 / 𝗖𝗼𝗮𝘁𝗶𝗻𝗴 6️⃣ 𝗙𝗶𝗻𝗮𝗹 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 & 𝗜𝗻𝘀𝗽𝗲𝗰𝘁𝗶𝗼𝗻 7️⃣ 𝗖𝗮𝗹𝗶𝗯𝗿𝗮𝘁𝗶𝗼𝗻, 𝗖𝗼𝗻𝘁𝗿𝗼𝗹 & 𝗔𝘂𝗱𝗶𝘁 8️⃣ 𝗙𝗶𝗻𝗮𝗹 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 & 𝗛𝗮𝗻𝗱𝗼𝘃𝗲𝗿 ────────────────────────────── 📄 𝗞𝗲𝘆 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝘀 𝗜𝗻𝗰𝗹𝘂𝗱𝗲: ────────────────────────────── • PQP (Project Quality Plan) • ITP (Inspection & Test Plan) • WPS / PQR / WQR • Material Test Certificates (MTC) • Fit-Up & Welding Inspection Reports • NDT Reports – VT, PT, MT, UT, RT • DFT, Holiday & Adhesion Test Reports • Calibration, NCR, CAR/PAR Logs • MRB, As-Built Drawings & Dispatch Certificates ────────────────────────────── 💡 𝗞𝗲𝘆 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ────────────────────────────── ✅ QA/QC documentation ensures traceability, transparency & trust. ✅ Each stage of fabrication has its own documentation trail. ✅ Proper documentation = zero confusion during audits. #QualityDocumentation #QAQC #QADocuments #InspectionEngineer #FabricationIndustry #ISO9001 #QualityManagement #ProjectQuality #QualityControl #QCEngineer #QualityAssurance #EngineeringDocumentation #Fabrication #WeldingInspection #NDT #PaintingInspection #ConstructionQuality #ManufacturingQuality #IndustrialInspection #MechanicalEngineering #StructuralFabrication #PressureVessel #PipelineInspection #ThirdPartyInspection #QualityEngineer #QAQCProfessional #QMS #AuditReadiness #ProcessImprovement #QualityLeadership #NonDestructiveTesting #WeldingQuality #ISOStandards #QualityCulture #EngineeringProjects #FabricationShop #WeldInspector #InspectionReports #MTC #DocumentationExcellence #ContinuousImprovement

Quality Control Records in the food industry are detailed documentation maintained throughout production to ensure compliance with quality standards and regulatory requirements. These records serve as a foundation for traceability, audits, and quality assurance. Key Types of QC Records in the Food Industry 1. Raw Material Inspection Records - Details of raw material receipt (supplier, lot numbers). - Certificates of analysis (CoA). - Results of inspections (e.g., visual checks, weight, temperature). 2. Processing Control Records - Critical Control Points (CCPs): Monitoring data for temperature, time, pressure, etc. - Calibration logs for equipment. - Records of deviations and corrective actions. 3. Packaging and Labeling Records - Weight/volume control checks. - Labeling accuracy (allergen information, expiry date). - Packaging integrity tests (leakage, sealing strength). 4. Finished Product Testing Records - Microbiological analysis results (e.g., Salmonella, Listeria). - Chemical analysis (e.g., pH, fat, sugar content). - Sensory evaluation results (taste, texture, appearance). 5. Hygiene and Sanitation Records - Cleaning schedules and verification logs. - Employee hygiene compliance (handwashing, PPE usage). - Swab test results for equipment and surfaces. 6. Storage and Transportation Records - Storage temperature and humidity logs. - Transportation conditions (e.g., refrigerated trucks). - Inspection of transport vehicles. 7. Non-Conformance and Corrective Action Records - Description of non-conformance (e.g., contamination, labeling errors). - Root cause analysis. - Details of corrective and preventive actions taken. 8. Regulatory and Certification Records - HACCP/ISO 22000 compliance documentation. - Regulatory inspection reports. - Third-party audit reports and certificates. #qc #qcrecords #foodindustry #foodsafety #quality #hygiene #food #allaboutfood #haccp #iso

Key Documents Prepared by QA/QC Inspectors 1-Method Statement (MOS): A detailed document describing the methodology, materials, tools, and sequence of activities to execute specific tasks in compliance with project standards. 2-Risk Assessment (RA): A document identifying potential hazards and risks associated with construction activities, along with proposed mitigation measures to ensure workplace safety. 3-Project Quality Plan (PQP): A comprehensive document outlining the quality control measures, procedures, and responsibilities to achieve the required project quality. 4-Inspection and Test Plan (ITP): A document specifying key stages where inspections and testing are carried out to ensure compliance with the approved specifications. 5-Inspection Checklist (ICL): A checklist used during inspections to verify that all required steps, specifications, and standards are adhered to. 6-Material Inspection Request (MIR): A request submitted to inspect and approve materials delivered to the site before their use in construction. 7-Work Inspection Request (WIR) / Request for Inspection (RFI): A formal request to conduct an inspection of completed work to ensure it meets the design and quality requirements. 8-Site Observation Report (SOR): A document used to log observations made during site visits, including any deviations from approved procedures or standards. 9-Non-Conformance Report (NCR): A formal report documenting instances where work, materials, or processes fail to meet specified standards, requiring corrective actions. 10-Corrective Action Report (CAR): A follow-up report detailing the actions taken to resolve non-conformances identified during inspections. 11-Operation & Maintenance Manuals (O&M): Comprehensive documentation that includes detailed operating procedures, maintenance schedules, and troubleshooting guides for all systems and equipment handed over to the client. 12-Final Handover Documents: A package of key documents provided to the client at the conclusion of the project, typically including as-built drawings, test certificates, warranties, O&M manuals, and other necessary documentation.

📝🔍 First Routine Monitoring Visit: Essential Documents for CRAs! 🔍📝   As CRAs, our first routine monitoring visit after the Site Initiation Visit (SIV) is pivotal in ensuring the smooth progress of clinical trials.   During this critical visit, there are several essential documents that we must diligently confirm, review, and collect to uphold data integrity and compliance. Let's highlight these key documents:   🔹 Informed Consent Form (ICF): Verify that the ICF is the most updated version of the document. If any patients were enrolled, ensure that each study participant or their legally authorized representative appropriately signed and dated the ICF. Confirm that the informed consent process followed regulatory guidelines.   🔹 Source Documents: Conduct thorough Source Data Verification (SDV) to validate that the Case Report Form (CRF) data matches the source documents, such as medical records, lab reports, and patient diaries.   🔹 Regulatory Documents: Collect and review essential regulatory documents, including the signed protocol, Investigator's Brochure (IB), IRB/EC approvals, Financial Disclosure Forms (FDFs), and any relevant correspondence.   🔹 Training Records: Ensure that all site personnel involved in the study have completed the required training, as documented in the Training Log or personnel files.   🔹 Site Delegation of Authority (DoA) Log: Verify that the DoA Log is up-to-date and accurately reflects the delegation of responsibilities among site staff.   🔹 Adverse Event Reporting: If an AEs or SAEs have been reported, review records of any reported adverse events (AEs) or Serious Adverse Events (SAEs), confirming appropriate documentation and follow-up.   🔹 Drug Accountability: Verify the accountability of investigational products, ensuring proper storage, dispensing and reconciliation of study medications.   🔹 Monitoring Visit Reports (MVRs): Confirm and review MVRs from previous visits, the SSV, and SIV, to ensure proper filing and retention, as well as tracking of site activities and any identified issues.   🔹 Study-Specific Logs and Worksheets: Check study-specific logs, such as the Subject Screening Log, Enrollment Log, and Randomization Log, to monitor study progress and patient recruitment.   A comprehensive review of these essential documents during the first RMV empowers CRAs to identify potential issues early on, ensure data accuracy, maintain regulatory compliance, and contribute significantly to the trial's success.   #ClinicalResearch #CRACareer #MonitoringVisit #DataIntegrity #RegulatoryCompliance #ClinicalTrials #ResearchExcellence #QualityAssurance

To maintain records for Welding Procedure Specification (WPS) qualification, comprehensive documentation is required to comply with codes like ASME Section IX, AWS D1.1, or API 1104. Key documents include: 1. **WPS**: Details welding parameters (base/filler metal, process, joint design, preheat, shielding gas). Signed and dated. 2. **Procedure Qualification Record (PQR)**: Records actual welding conditions and test results (tensile, bend, impact). References WPS, signed by a qualified person. 3. **Test Reports**: - **Mechanical Tests**: Tensile, bend, or impact (e.g., Charpy) results, with acceptance criteria and lab certification. - **Non-Destructive Examination (NDE)**: Radiographic (RT), ultrasonic (UT), or other test reports, signed by inspectors. 4. **Welder Performance Qualification (WPQ)**: Records welder’s test details, linking to WPS, with visual or NDE results, signed. 5. **Material Test Reports (MTRs)**: Certificates for base/filler metals, showing chemical and mechanical properties, heat/lot numbers. 6. **Welding and Inspection Records**: Logs of parameters (voltage, amperage, travel speed) and inspection checklists. 7. **Calibration Certificates**: For welding and NDE equipment, proving functionality. 8. **Code Compliance**: Reference to the standard (e.g., ASME IX), including heat treatment records if needed. 9. **Traceability**: Unique IDs for WPS, PQR, and coupons, ensuring linkage. 10. **Signatures**: From engineers, inspectors, or labs, verifying compliance. Records must be organized, retained (often 5+ years), and auditable. Specific codes may add requirements.

💡 What is EDL in TMF and Why Is It Important?🗂️ The Essential Document List (EDL) is a critical component of the Trial Master File (TMF) in clinical research. It serves as the foundation for ensuring that all required documents are properly managed and maintained throughout the lifecycle of a clinical trial. These documents provide evidence that the study was conducted in compliance with Good Clinical Practices (GCP) and regulatory requirements. 📌 Why Does EDL Matter? • Regulatory Compliance: Ensures clinical trials meet global regulatory standards. • Audit and Inspection Readiness: Helps trial teams prepare for audits and regulatory inspections. • Study Oversight: Provides visibility into trial progress and adherence to protocols. • Risk Mitigation: Ensures complete and accurate documentation to reduce risks. 🗂️ Key Components of an EDL: 1. Trial Set-Up Documents: • Study protocol • Investigator brochure • Regulatory authority approvals 2. Ethics and Regulatory Submissions: • IRB/EC approvals • Regulatory correspondence 3. Site Management Documents: • Site selection reports • Site agreements • Delegation logs 4. Subject-Related Documents: • Informed consent forms • Case report forms (CRFs) 5. Data Management Documents: • Data validation plans • Database specifications 6. Safety Monitoring: • Adverse event reports • Safety monitoring committee documentation 7. Closeout Documents: • Final clinical trial reports • Archiving certificates 🔧 How Is the EDL Created? • Identify required documents based on regulatory guidelines (ICH E6 (R2)). • Categorize documents by trial phase and responsible party. • Use standardized TMF templates and eTMF systems (e.g., Veeva Vault). • Assign ownership for document collection, review, and maintenance. • Implement quality control and version management processes. 💭 Why Care About EDL? A well-structured and maintained EDL can make a significant difference in the success of clinical trials by improving operational efficiency, supporting compliance, and simplifying audit processes. #ClinicalResearch #EDL #TrialMasterFile #GCP #Compliance #ClinicalTrials #Inspection.

🔍 Labor Market Inspections in Switzerland: Are You Prepared? 🇨🇭 https://lnkd.in/dhdUqx97 Swiss companies are currently facing intensified scrutiny by labor market authorities, especially regarding the employment of posted workers. Labor inspectors are making on-site visits to ensure compliance with Switzerland's strict accompanying measures (FLAM). 👥 What does this mean for businesses? Inspectors are checking whether all necessary documentation for foreign employees is readily available—this includes work permits and notification copies. But one of the most critical points is the payment of Swiss local and industry-standard minimum wages. 📄 What should you prepare for? The labor inspector will request proof of wage payments (including payslips and payment transactions) to verify compliance with minimum wage regulations. Additionally, be prepared to provide documentation of posting-related expenses, which must be covered by the foreign employer. 💡 Our recommendation: Ensure that your Swiss client or company has copies of all relevant notifications and permits. Staying compliant not only helps avoid penalties but ensures smooth cooperation during inspections. Is your company ready for the next inspection? #SwissLaborMarket #PostedWorkers #Compliance #MinimumWage #LaborInspection #HR #SwissBusiness

✨Are you preparing your investigator site files (ISF) for an audit? Pay attention to the following items: ♦️Site responsibility log (SRL) or delegation log -Curriculum vitae (CV) and medical licenses are on file and current. -PI signed and dated delegated duties before involving staff in the study. -Updated log with additions and deletions in staff -Staff trained on the study before performing study-related duties ♦️Form FDA 1572 -PI’s name is consistent on the Form FDA 1572, CV, financial disclosure form, and medical license  -PI’s affiliation on the CV is consistent with the site address on Form FDA 1572. -List of all investigators and study staff in section 6. -Names, addresses, etc. are correct and consistent for all investigator sites, IP shipment addresses, laboratory facilities, and institutional review boards (IRBs). -Certification and normal reference range document names are consistent. -Correctly listed protocol number and title. -Form FDA 1572 is signed and dated by the PI with any changes initialed and dated by the PI. ♦️Financial disclosure forms -Present, original, signed, and dated for all staff on Form FDA 1572. ♦️Screening/enrollment log -Reason for screen failure or randomization date recorded for all screened participants. ♦️Protocol and amendments -All are on file and signed/dated by the PI. ♦️IRB communications -Documentation is complete (protocol; IB; ICF documents, etc.). -Filed IRB list or assurance letter and continuing review approval. -Notification and report of protocol deviations and SAEs  -ISF contains all IRB-approved documents. -The site uses approved/current versions of each document -Stamped IRB-approved ICFs ♦️Training and qualification documentation -Signed and dated current CVs containing name, education and qualification, current position, affiliation(s), and experience of staff. -Medical licenses are valid for the duration of staff involvement in the study. -Documented training of relevant staff on study materials, eCRF, and GCP. ♦️Investigational New Drug (IND) safety reports -Sponsor-submitted reports are present, submitted to the IRB, and documents PI review. ♦️Lab accreditation and reference ranges for laboratories -Accreditation is valid for the duration of the study, and reference ranges are on file and current. ♦️Communications -Documented correspondence about safety, protocol deviations, IRB notifications, and key study decisions. -Monitoring visit confirmation letters and follow-up letters are on file. -Documented evidence of timely resolution of issues.  -Safety questions, inclusion/exclusion criteria, and newsletters are present. ♦️Site visit log -All visits are recorded and consistent with monitoring visit documentation. ♦️Pharmacy file -Inventory records are up to date. -Documentation of IP dispensing, return, or destruction is present. -Determine if there is a separate delegation log in the pharmacy or included in ISF. #clinicalresearch #clinicaltrials

Most sites assume the central lab maintains the chain.  The central lab assumes the site maintains it at the source. Both are partially right.  Together they create the gap FDA reads as a finding. Why is this being probed now? FDA's January 2025 draft guidance on tissue biopsies signaled the trajectory. Biospecimen chain of custody, biobank samples, genomic specimens, central lab routines, future-research consents is now actively probed at site inspections. What are the 5 requirements FDA checks? 1. Collection-Event Documentation at the Source : Date, time, collector identity, subject verification, specimen type, volume, container identifier all documented contemporaneously at the moment of collection. Common gap: collection documented in the EDC but the source document, lab requisition, chain-of-custody form, collection log doesn't carry the same timestamp and collector details. 2. Subject-Consent-to-Sample-Use Traceability : For each specimen, can the site trace the specific consent authorizing its use? Primary study only, biobank storage, future research, genomic analysis what was authorized and what wasn't? Common gap: consent allows primary study use but not future research. The sample ships to the lab with no metadata distinguishing it from future-research-consented samples. This is where 21 CFR 50.25 findings most often originate. 3. Site-to-Lab Transfer Documentation : What left the site, when, who packed it, temperature integrity during transit, what was received at the lab. Common gap: shipments documented at the courier level ("3 boxes sent Tuesday") rather than specimen level ("Subject 0042 PK sample 1 of 4"). 4. Reconciliation Between Site and Lab Records : Can the site reconcile collection records against lab receipt and storage records, identifying samples present at one but not the other? Common gap: reconciliation happens informally during monitoring visits. No documented site-level cycle. When samples are lost or mis-cataloged, discrepancies aren't identified until someone asks which may be years later. 5. Long-Term Retention and Disposition : For specimens stored beyond study completion, documentation of storage location, custody arrangements, and disposition decisions including destruction when subjects withdraw consent. Common gap: withdrawal of consent captured in the consent file but never communicated to the biobank. The bank continues holding samples the subject withdrew consent for. What should your team check this week? • Check all 5 requirements for site-level documentation. • For any gap, determine whether documentation exists only at the lab or doesn't exist at all. • If it exists only at the lab, the site has delegated chain-of-custody responsibility without retaining oversight. Which of the 5 requirements would your site find weakest tomorrow? ♻️ Repost this to help your network get started ➕ Follow Ben for more Start your free trial today. #FDAInspection #ClinicalResearch #Biospecimen